GAMMAGARD LIQUID for Multifocal Motor Neuropathy (MMN) Resources
Support for your patients with MMN
To support your efforts in meeting patient needs, we’ve created a resource library full of helpful materials for you. You’ll also find helpful information you can pass along to your MMN patients and their loved ones.
MMN resources for healthcare professionals
Watch how GAMMAGARD LIQUID is made
See the product characteristics in this introduction to the creation process.
Watch nowProduct Characteristics Brochure
Not all IVIG formulations are interchangeable.2 In this brochure, you’ll find GAMMAGARD LIQUID information related to formulation, dosage, infusion rate, and packaging along with patient risk conditions and risk factors to consider with IVIG administration.
Download product characteristicsClinical Overview Brochure
This overview contains information on the study design, results, safety profile, and infusion experience for GAMMAGARD LIQUID’s clinical trial in MMN.
Download clinical overviewUse the diagnosis code ICD-10-CM G61.82 when prescribing GAMMAGARD LIQUID for MMN patients.
Takeda Patient Support* Co-Pay Assistance Program
When your patient enrolls, we’re here to help them gain access to their prescribed Takeda medication. Our dedicated specialists provide several services, including:
- Benefits investigation to help determine your patient’s insurance benefits
- Prior authorization (PA), reauthorization, and appeals information in coordination with your patient’s insurance company to determine any requirements
- Financial assistance options including the Takeda Patient Support Co-Pay Assistance Program. The program may cover up to 100% of your patient’s out-of-pocket co-pay costs, if they’re eligible*†
- Education and training about their prescribed Takeda treatment or condition from nursing professionals. Our nurses cannot provide medical advice
- Specialty pharmacy triage, coordination, and more‡
Need Assistance?
Our support specialists are never more than
a tap or call away — 1-866-861-1750,
Monday through Friday, 8 am to 8 pm ET.
Need to enroll your patient?
Visit our convenient online enrollment portal
at TakedaPatientSupport.com/hcp.
You can also enroll your patient by faxing the
completed Start Form to 1-855-268-1826.
If English is not your patient’s preferred language, we can assist them in a language of their choosing.
*Must meet eligibility requirements.
*IMPORTANT NOTICE: Takeda’s Co-pay Assistance Program ("the Program") provides financial support for commercially insured patients who qualify for the Program. Participation in the Program and
provision of financial support is subject to all Program terms and conditions, including but not limited to eligibility requirements, the Program maximum benefit per claim and the annual calendar year Program
maximum (“Annual Program Maximum”). The Annual Program Maximum for your prescribed Takeda product can be found by visiting: https://www.takedapatientsupport.com/s/copay. By enrolling in the Program, you agree that the Program is intended solely for the benefit of you—not health plans and/or their partners. Further, you agree to comply with all applicable requirements of your
health plan. The Program cannot be used if the patient is a beneficiary of, or any part of the prescription is covered by: 1) any federal, state, or government-funded healthcare program (Medicare, Medicare
Advantage, Medicaid, TRICARE, etc.), including a state pharmaceutical assistance program (the Federal Employees Health Benefit (FEHB) Program is not a government-funded healthcare program for
the purpose of this offer), 2) the Medicare Prescription Drug Program (Part D), or if the patient is currently in the coverage gap, or 3) insurance that is paying the entire cost of the prescription. No claim for
reimbursement of the out-of-pocket expense amount covered by the Program shall be submitted to any third-party payer, whether public or private.
Some health plans have established programs referred to as ‘co-pay maximizer’ programs. A co-pay maximizer program is one in which the amount of a patient’s out-of-pocket costs is adjusted to reflect the
availability of support offered by a manufacturer’s co-pay assistance program. If you are enrolled in a co-pay maximizer program, your Annual Program Maximum may vary over time to ensure the program
funds are used for your benefit (for the benefit of the patient). Takeda also reserves the right to reduce or eliminate the co-pay assistance available to patients enrolled in an insurance plan that utilizes a co-pay
maximizer program.
If you learn your health plan has implemented a co-pay maximizer program, you agree to notify the Program immediately by calling 1-866-861-1750. It may be possible that you are unaware whether you are subject to a co-pay maximizer program when you enroll or re-enroll in the Program. Takeda will monitor program utilization data and reserves the right to discontinue assistance under the Program at any time if Takeda determines that you are subject to a co-pay maximizer, or similar program.
The Program only applies in the United States, including Puerto Rico and other U.S. territories, and does not apply where prohibited by law, taxed, or restricted. This does not constitute health insurance.
Void where use is prohibited by your insurance provider. If your insurance situation changes you must notify the Program immediately at 1-866-861-1750. Coverage of certain administration charges will not apply for patients residing in states where it is prohibited by law.
This Program offer is not transferable and is limited to one offer per person and may not be combined with any other coupon, discount, prescription savings card, rebate, free trial, patient assistance, co-pay
maximizer, alternative funding program, co-pay accumulator, or other offer, including those from third parties and companies that help insurers or health plan manage costs. Not valid if reproduced.
By utilizing the Program, you hereby accept and agree to abide by these terms and conditions. Any individual or entity who enrolls or assists in the enrollment of a patient in the Program represents that the
patient meets the eligibility criteria and other requirements described herein. You must meet the Program eligibility requirements every time you use the Program. Takeda reserves the right to rescind, revoke, or
amend the Program at any time without notice, and other terms and conditions may apply.
‡If your patients’ medication is dispensed by specialty pharmacy. US-NON-9235v1.0 02/23
Resources for patients with MMN
GAMMAGARD LIQUID Treatment Brochure
Use this brochure to help patients explore treatment with GAMMAGARD LIQUID and to provide an overview of the infusion process, working with a specialty pharmacy, and more.
Download treatment brochureMMN Electrodiagnostic Testing Overview
For your patients who need electrodiagnostic testing, this resource helps them understand what to expect during the procedure and why testing is important.
Download the overviewThird-party links for MMN patients
An MMN diagnosis can bring a range of emotions, from confusion to relief. Many patients and their loved ones benefit from connecting with support from patient organizations.
Neuropathy Action Foundation (NAF)
This helpful organization posts brochures, news, and quarterly newsletters and provides information on navigating insurance.
Visit neuropathyaction.orgThe Foundation for Peripheral Neuropathy
Along with helpful information about living with neuropathies, this organization provides opportunities for patients to connect with support groups.
Visit foundationforpn.orgThe GBS/CIDP Foundation International
This organization provides support for patients with several related conditions—including MMN—and ways to connect with other patients.
Visit gbs-cidp.org